AI assistant
Sending…
RESMED INC — Director's Dealing 2012
Nov 21, 2012
30071_dirs_2012-11-21_88d86154-a6ab-43c7-8ea6-9a6071592e1f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-11-20
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-20 | ResMed Common Stock | M | 6443 | $15.520 | Acquired | 65717 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-20 | ResMed Stock Options | $15.520 | M | 6443 | Disposed | 2015-11-20 | ResMed Common Stock (6443) | Direct |
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29